These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 12919492)

  • 1. Topiramate: potential trade-offs between efficacy and tolerability in the treatment of epilepsy.
    Harvey AS
    J Paediatr Child Health; 2003 Aug; 39(6):414-5. PubMed ID: 12919492
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of topiramate on cognition.
    Meador KJ
    J Neurol Neurosurg Psychiatry; 2001 Jul; 71(1):134-5. PubMed ID: 11439970
    [No Abstract]   [Full Text] [Related]  

  • 3. Long-term treatment retention with topiramate.
    Deckers CL; Renier WO
    Epilepsia; 2001 Feb; 42(2):290-1. PubMed ID: 11240609
    [No Abstract]   [Full Text] [Related]  

  • 4. Erectile dysfunction with topiramate.
    Holtkamp M; Weissinger F; Meierkord H
    Epilepsia; 2005 Jan; 46(1):166-7. PubMed ID: 15660786
    [No Abstract]   [Full Text] [Related]  

  • 5. [Compared clinical study on treatment of childhood epilepsy with different escalating dosage protocol of topiramate].
    Huang SP; He GZ; Chen ZQ; He J
    Zhonghua Er Ke Za Zhi; 2003 Mar; 41(3):230-2. PubMed ID: 14756968
    [No Abstract]   [Full Text] [Related]  

  • 6. Using topiramate in patients with epilepsy: practical aspects.
    Sander JW
    Can J Neurol Sci; 1998 Aug; 25(3):S16-8. PubMed ID: 9706736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topiramate extended-release (Trokendi XR) for epilepsy.
    Med Lett Drugs Ther; 2013 Oct; 55(1428):87-8. PubMed ID: 24165709
    [No Abstract]   [Full Text] [Related]  

  • 8. Topiramate for epilepsy.
    Med Lett Drugs Ther; 1997 May; 39(1001):51-2. PubMed ID: 9164447
    [No Abstract]   [Full Text] [Related]  

  • 9. Topiramate: new indication. A bulkier assessment file.
    Prescrire Int; 1999 Oct; 8(43):141-2. PubMed ID: 11503838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Weight loss associated with topiramate treatment].
    Maciá- Bobes C; Cortejoso-García R; Carrio-Montes I; Arias Rodríguez M
    Rev Neurol; 2002 Feb 16-28; 34(4):397. PubMed ID: 12022061
    [No Abstract]   [Full Text] [Related]  

  • 11. [Psychosis following treatment with topiramate].
    Voskuil PH
    Ned Tijdschr Geneeskd; 2003 Feb; 147(7):319-20; author reply 320. PubMed ID: 12622013
    [No Abstract]   [Full Text] [Related]  

  • 12. Reversible facial myoclonus with topiramate therapy for epilepsy.
    Kutluay E; Pakoz B; Beydoun A
    Epilepsia; 2007 Oct; 48(10):2001-2. PubMed ID: 17922777
    [No Abstract]   [Full Text] [Related]  

  • 13. [Topiramate: a broad-spectrum antiepileptic drug? Sixth meeting of the European Neurological Society. Den Haag, 8 June 1996].
    Fortschr Neurol Psychiatr; 1996 Sep; 64(9 Suppl):1-8. PubMed ID: 9022373
    [No Abstract]   [Full Text] [Related]  

  • 14. Topiramate therapy of epilepsy associated with Angelman's syndrome.
    Franz DN; Glauser TA; Tudor C; Williams S
    Neurology; 2000 Mar; 54(5):1185-8. PubMed ID: 10720296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topiramate and metabolic acidosis.
    Wilner A; Raymond K; Pollard R
    Epilepsia; 1999 Jun; 40(6):792-5. PubMed ID: 10368081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Practical aspects of the use of topiramate in patients with epilepsy.
    Sander JW
    Epilepsia; 1997; 38 Suppl 1():S56-8. PubMed ID: 9092962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tolerability and safety of topiramate in Chinese patients with epilepsy : an open-label, long-term, prospective study.
    Lu Y; Wang X; Li Q; Li J; Yan Y
    Clin Drug Investig; 2007; 27(10):683-90. PubMed ID: 17803343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Experience in combined topiramate therapy of drug-resistant epilepsy].
    Karlov VA; Vlasov PN; Freĭdkova NV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2003; 103(7):21-6. PubMed ID: 12938650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and tolerability of topiramate in children younger than 2 years old.
    Valencia I; Fons C; Kothare SV; Khurana DS; Yum S; Hardison HH; Legido A
    J Child Neurol; 2005 Aug; 20(8):667-9. PubMed ID: 16225812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical experience with open-label topiramate use in infants younger than 2 years of age.
    Watemberg N; Goldberg-Stern H; Ben-Zeev B; Berger I; Straussberg R; Kivity S; Kramer U; Brand N; Lerman-Sagie T
    J Child Neurol; 2003 Apr; 18(4):258-62. PubMed ID: 12760428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.